- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents ; volume:5 ; number:1 ; day:28 ; month:9 ; year:2024 ; pages:1-19 ; date:12.2024
Molecular biomedicine ; 5, Heft 1 (28.9.2024), 1-19, 12.2024
- Creator
-
Dhas, Yogita
Biswas, Nupur
M.R., Divyalakshmi
Jones, Lawrence D.
Ashili, Shashaanka
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-024-00204-z
- URN
-
urn:nbn:de:101:1-2412012108320.282069521106
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
11.06.2002, 1:41 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dhas, Yogita
- Biswas, Nupur
- M.R., Divyalakshmi
- Jones, Lawrence D.
- Ashili, Shashaanka
- SpringerLink (Online service)
Other Objects (12)
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
Heterocyclic anticancer agents
Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
The effects of antidiabetic agents on heart failure
Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
Thiadiazole derivatives as anticancer agents
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Similarity searching for anticandidal agents employing a repurposing approach
Repurposing metformin as a potential anticancer agent using in silico technique
In the Search of Glycoside-Based Molecules as Antidiabetic Agents
Structure‐Agnostic Bioactivity‐Driven Combinatorial Biosynthesis Reveals New Antidiabetic and Anticancer Triterpenoids
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
Heterocyclic anticancer agents
Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
The effects of antidiabetic agents on heart failure
Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
Thiadiazole derivatives as anticancer agents
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Similarity searching for anticandidal agents employing a repurposing approach
Repurposing metformin as a potential anticancer agent using in silico technique
In the Search of Glycoside-Based Molecules as Antidiabetic Agents
Structure‐Agnostic Bioactivity‐Driven Combinatorial Biosynthesis Reveals New Antidiabetic and Anticancer Triterpenoids
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
Heterocyclic anticancer agents
Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
The effects of antidiabetic agents on heart failure
Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
Thiadiazole derivatives as anticancer agents
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Similarity searching for anticandidal agents employing a repurposing approach
Repurposing metformin as a potential anticancer agent using in silico technique
In the Search of Glycoside-Based Molecules as Antidiabetic Agents